Rohin Patel

Stock Analyst at JP Morgan

(1.32)

# 3,586

Out of 5,173 analysts

5

Total ratings

66.67%

Success rate

-1.95%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Rohin Patel

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	HAE Haemonetics	Maintains: Neutral	$62 → $74	$58.46	+26.58%	3	Dec 12, 2025
	NPCE NeuroPace	Maintains: Overweight	$18 → $20	$13.38	+49.48%	2	Dec 10, 2025

Haemonetics

Dec 12, 2025

Maintains: Neutral

Price Target: $62 → $74

Current: $58.46

Upside: +26.58%

NeuroPace

Dec 10, 2025

Maintains: Overweight

Price Target: $18 → $20

Current: $13.38

Upside: +49.48%